Investment Review №349. High Hopes

Trade Thesis

A moderately aggressive two-week bet on continued banking momentum in Morgan Stanley through a $230-strike call option expiring on August 21, 2026. The idea is supported by the bank’s solid capital position after the Federal Reserve stress tests, the dividend increase, the new $20B share repurchase authorization and the potential continuation of strength in investment banking and trading revenues ahead of the earnings season.

Key Arguments

• Fed stress tests created room for capital return. After passing the stress tests, Morgan Stanley announced a higher quarterly dividend and a new multi-year $20B share repurchase program, confirming a solid capital position and supporting the investment case.
• A stronger investment banking cycle can support earnings. Recovering activity in issuance, M&A and corporate financing may continue to drive re-rating for large investment banks, especially if the next earnings report confirms stronger fee income.
• Trading revenues and wealth management make the story more resilient. Client activity in equities and fixed income supports Institutional Securities, while the large wealth management franchise reduces reliance on the more volatile investment banking cycle.

Risk Managеment

If MS closes above $230 but below $238.25 at expiration on 08/21/2026, the investor will realize a partial loss depending on the final stock price. If the stock closes below $230, the maximum loss equals the premium paid — $825. If the stock closes above the breakeven of $238.25, the position becomes profitable at expiration. The base case is to hold until the target premium of $15.90 is reached. Key risks include profit taking after the strong rally, normalization of trading revenues, weaker M&A and IPO activity, changing rate expectations and a broader decline in risk appetite. If the stock trades sideways, time decay will work against the position.

Trade parameters

P/L of the Option Strategy